A raising dawn of pentoxifylline in management of inflammatory disorders in Covid-19
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Immunology
Link
https://link.springer.com/content/pdf/10.1007/s10787-022-00993-1.pdf
Reference100 articles.
1. Abdel-Salam OM, Baiuomy AR, El-Shenawy SM, Arbid MS (2003) The anti-inflammatory effects of the phosphodiesterase inhibitor pentoxifylline in the rat. Pharmacol Res 47:331–340
2. Abdul Hadi ME, Hisham A (2011) Pentoxifylline as a successful drug treatment for disseminated intravascular coagulopathy in Kassabach–Merrit syndrome. Sudan Med Monit 6(2):89–91
3. Abouelkhair MA (2020) Targeting adenosinergic pathway and adenosine A2A receptor signaling for the treatment of COVID-19: a hypothesis. Med Hypotheses 144:110012
4. Al-Kuraishy HM, Al-Gareeb AI (2017) Comparison of deferasirox and deferoxamine effects on iron overload and immunological changes in patients with blood transfusion-dependent β-thalassemia. Asian J Transfus Sci 11(1):13
5. Al-Kuraishy HM, Al-Gareeb AI (2021) Acute kidney injury and COVID-19. Egypt J Intern Med 33:1–5. https://doi.org/10.1186/s43162-021-00064-x
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Depression and type 2 diabetes: A causal relationship and mechanistic pathway;Diabetes, Obesity and Metabolism;2024-05-27
2. The effect of pentoxifylline and different types of exercise training on coagulation factors in a rat endometriosis model;European Journal of Obstetrics & Gynecology and Reproductive Biology: X;2024-03
3. Isolated Depo-Medrol Administration under Tenon’s Capsule for Post-COVID-19 Uveitis in a Child: A Case Report and Literature Review;Journal of Clinical Medicine;2024-02-27
4. Covid‐19 and risk of acute pancreatitis: What beyond;Journal of Cellular and Molecular Medicine;2023-12-15
5. The possible role of nuclear factor erythroid‐2‐related factor 2 activators in the management of Covid‐19;Journal of Biochemical and Molecular Toxicology;2023-12-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3